FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between Emcure Pharma IPO and Vraj Iron and Steel IPO.
Emcure Pharma IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Vraj Iron and Steel IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.
Emcure Pharma IPO | Vraj Iron and Steel IPO | |
---|---|---|
Logo | ||
Issue Category | Mainline | Mainline |
Issue Type | IPO | IPO |
Process Type | Book Built Issue | Book Built Issue |
Listing At | BSE, NSE | BSE, NSE |
Lead Managers | Kotak Mahindra Capital Company Limited Axis Capital Limited J.P. Morgan India Private Limited Jefferies India Private Limited |
Aryaman Financial Services Limited |
Registrar | Link Intime India Private Ltd | Bigshare Services Pvt Ltd |
Market Maker | ||
DRHP | DRHP | DRHP |
RHP | RHP | RHP |
Anchor Investor | Anchor Investor | Anchor Investor |
IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Emcure Pharma IPO is up to ₹1,952.03 Cr whereas the issue size of the Vraj Iron and Steel IPO is up to ₹171.00 Cr. The final issue price of Emcure Pharma IPO is ₹1,008.00 per share and of Vraj Iron and Steel IPO is ₹207.00 per share.
Emcure Pharma IPO | Vraj Iron and Steel IPO | |
---|---|---|
Face Value | ₹10 per share | ₹10 per share |
Issue Price (Lower) | ₹960.00 per share | ₹195.00 per share |
Issue Price (Upper) | ₹1,008.00 per share | ₹207.00 per share |
Issue Price (Final) | ₹1,008.00 per share | ₹207.00 per share |
Discount (Retail) | ||
Discount (Employee) | ₹90.00 per share | |
Market Lot Size | 14 shares | 72 shares |
Fresh Issue Size | 79,36,507 shares | 82,60,870 shares |
Fresh Issue Size (Amount) | up to ₹800.00 Cr | up to ₹171.00 Cr |
OFS Issue Size | 1,14,28,839 shares | |
OFS Issue Size (Amount) | up to ₹1,152.03 Cr | |
Issue Size Total | 1,93,65,346 shares | 82,60,870 shares |
Issue Size Total (Amount) | up to ₹1,952.03 Cr | up to ₹171.00 Cr |
Emcure Pharma IPO opens on Jul 03, 2024, while Vraj Iron and Steel IPO opens on Jun 26, 2024. The closing date of Emcure Pharma IPO and Vraj Iron and Steel IPO is Jul 05, 2024, and Jun 28, 2024, respectively.
Emcure Pharma IPO | Vraj Iron and Steel IPO | |
---|---|---|
Anchor Bid Date | Jul 02, 2024 | Jun 25, 2024 |
Issue Open | Jul 03, 2024 | Jun 26, 2024 |
Issue Close | Jul 05, 2024 | Jun 28, 2024 |
Basis Of Allotment (Tentative) | Jul 08, 2024 | Jul 01, 2024 |
Initiation of Refunds (Tentative) | Jul 09, 2024 | Jul 02, 2024 |
Credit of Share (Tentative) | Jul 09, 2024 | Jul 02, 2024 |
Listing date (Tentative) | Jul 10, 2024 | Jul 03, 2024 |
Anchor Lockin End date 1 | Aug 07, 2024 | Jul 31, 2024 |
Anchor Lockin End date 2 | Oct 06, 2024 | Sep 29, 2024 |
Emcure Pharma IPO P/E ratio is 34.55, as compared to Vraj Iron and Steel IPO P/E ratio of 9.48.
Emcure Pharma IPO | Vraj Iron and Steel IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial | Emcure Pharmaceuticals Limited Financial Information (Restated Consolidated)Emcure Pharmaceuticals Limited's revenue increased by 11.33% and profit after tax (PAT) dropped by -6.1% between the financial year ending with March 31, 2024 and March 31, 2023.
|
Vraj Iron and Steel Limited Financial Information (Restated Consolidated)Vraj Iron and Steel Limited's revenue increased by 24.87% and profit after tax (PAT) rose by 88.12% between the financial year ending with March 31, 2023 and March 31, 2022.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | 98.90% | 99.99% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Post-Issue) | 78.24% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
P/E Ratio | 34.55 | 9.48 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Market Cap | ₹19029.89 Cr. | ₹682.74 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROE | 16.90%% | 23.78%% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROCE | 19.37%% | 25.34%% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt/Equity | 0.67 | 0.27 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
EPS | ₹29.17 | ₹21.84 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RoNW | 16.87%% | 23.78%% |
In the Emcure Pharma IPO retail investors (RII) are offered 67,43,160 shares while in Vraj Iron and Steel IPO retail investors are offered 67,43,160 shares. Qualified institutional buyers (QIB) are offered 38,53,234 shares in Emcure Pharma IPO and 16,52,174 shares in Vraj Iron and Steel IPO.
Emcure Pharma IPO | Vraj Iron and Steel IPO | |
---|---|---|
Anchor Investor Reserveration | 57,79,850 shares | 24,78,259 shares |
Market Maker Reserveration | ||
QIB | 38,53,234 shares | 16,52,174 shares |
NII | 28,89,926 shares | 12,39,130 shares |
RII | 67,43,160 shares | 28,91,305 shares |
Employee | 1,08,900 shares | 0 shares |
Others | ||
Total | 1,37,03,538 shares | 57,82,609 shares |
Emcure Pharma IPO subscribed 67.87x in total, whereas Vraj Iron and Steel IPO subscribed 126.36x.
Emcure Pharma IPO | Vraj Iron and Steel IPO | |
---|---|---|
QIB (times) | 191.24x | 173.99x |
NII (times) | 49.32x | 221.66x |
Big NII (times) | 54.90x | 217.50x |
Small NII (times) | 38.16x | 229.99x |
RII (times) | 7.36x | 58.31x |
Employee (times) | 8.81x | |
Other (times) | ||
Total (times) | 67.87x | 126.36x |
Add a public comment...
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|